Science Explorer Interactive view Map
Company · Tokyo · Japan

MSD K.K. (Japan)

In research, MSD K.K. (Japan) stands highest in Health Sciences (#12,791 of 20,462 worldwide) and Medicine (#11,849 of 17,978 worldwide), over all time.

msd.co.jpROR OpenAlex
World rank, 2022–2025
#21,016
of 28,054 · #23,703 all time
Rank in Japan
#618
of 1,070
Research works
366
▲ 108% vs 2013–17
Citations
7.1k
19.3 per fractional work
Top-10% rate
17.3%
record average 16.5%
Open access
57%
world 28%

What is MSD K.K. (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #12,791 of 20,462 18.2%177
MedicineField #11,849 of 17,978 17.0%165

Each strip is that field’s whole ranked pool, with the notch where MSD K.K. (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.64× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.32× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 4.11× its world share, 3 worksImmunology and Micro…Neuroscience: 0.67× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.29× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.31× its world share, 0 worksChemical EngineeringChemistry: 0.41× its world share, 0 worksChemistryComputer Science: 0.49× its world share, 3 worksComputer ScienceEngineering: 0.30× its world share, 3 worksEngineeringEnvironmental Science: 0.39× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.18× its world share, 0 worksMaterials ScienceMathematics: 2.18× its world share, 2 worksMathematicsPhysics and Astronomy: 0.21× its world share, 0 worksPhysics and AstronomyDentistry: 0.16× its world share, 0 worksDentistryHealth Professions: 0.63× its world share, 1 worksHealth ProfessionsMedicine: 2.64× its world share, 38 worksMedicineNursing: 0.63× its world share, 0 worksNursingArts and Humanities: 0.12× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.51× its world share, 1 worksBusiness, Management…Decision Sciences: 1.51× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 2.54× its world share, 4 worksEconomics, Econometr…Psychology: 1.10× its world share, 3 worksPsychologySocial Sciences: 0.30× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.1×. Every wedge is a field page.

Who are the top researchers at MSD K.K. (Japan)?

Ranked on the composite score, Kazuo Noguchi lead among researchers whose main affiliation is MSD K.K. (Japan).

  1. 1 Kazuo Noguchi Japan · #1,069,888 worldwide 18 citations · 17 works
All ranked researchers at MSD K.K. (Japan)

Which keywords describe research at MSD K.K. (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Vaccine Development, Clinical Practice Guidelines, Antimicrobial Resistance, Cost-effectiveness Analysis, Health Utility Measures, Vaccine and Community-Acquired Pneumonia.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology15▲ 5.1×39 topics
  2. Vaccine Development4▲ 21×3 topics
  3. Clinical Practice Guidelines3▲ 8.3×7 topics
  4. Antimicrobial Resistance3▲ 21×4 topics
  5. Quality of Life3▲ 2.7×9 topics
  6. Chemotherapy3▲ 5.0×13 topics
  7. Diagnosis3▲ 3.6×9 topics
  8. Cost-effectiveness Analysis2▲ 35×1 topic
  9. Health Utility Measures2▲ 35×1 topic
  10. Pandemic2▲ 2.9×3 topics
  11. Vaccine2▲ 7.5×6 topics
  12. Community-Acquired Pneumonia2▲ 86×1 topic
  13. Meta-Analysis2▲ 4.8×4 topics
  14. Pneumococcal Conjugate Vaccine2▲ 86×1 topic
  15. Human Metapneumovirus2▲ 62×1 topic
  16. Immune Response2▲ 4.9×7 topics
  17. Respiratory Syncytial Virus2▲ 62×1 topic
  18. Clinical Trials2▲ 3.9×7 topics
  19. Global Burden2▲ 4.8×5 topics
  20. SARS-CoV-22▲ 8.2×4 topics
  21. ACE2 Receptor2▲ 9.4×2 topics
  22. Antiviral Therapy2▲ 24×2 topics
  23. Cancer Incidence2▲ 18×4 topics
  24. Infection2▲ 9.7×3 topics
  25. Tumor Microenvironment2▲ 5.2×3 topics
  26. Antibiotic Resistance2▲ 6.0×5 topics
  27. Antiretroviral Therapy2▲ 14×4 topics
  28. Congenital Infection2▲ 73×1 topic
  29. Cytomegalovirus2▲ 73×1 topic
  30. Human Papillomavirus2▲ 18×2 topics
  31. Immune Checkpoint Blockade2▲ 20×1 topic
  32. Immunity2▲ 5.7×4 topics
  33. PD-1 and PD-L12▲ 20×1 topic
  34. Risk Perception2▲ 8.4×4 topics
  35. Transplant Recipients2▲ 39×2 topics
  36. Adverse Drug Reactions2▲ 37×3 topics
  37. Cervical Cancer1▲ 18×2 topics
  38. Chronic Cough1▲ 74×1 topic
  39. Circadian Rhythms1▲ 18×2 topics
  40. Cough Reflex Sensitivity1▲ 74×1 topic

Which research topics does MSD K.K. (Japan) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pneumonia and Respiratory Infections, Respiratory viral infections research and Cancer Immunotherapy and Biomarkers.

Health Systems, Economic…2Health Systems, Economic Evaluations, Quality of Life: 2 fractional worksPneumonia and Respirator…2Pneumonia and Respiratory Infections: 2 fractional worksRespiratory viral infect…2Respiratory viral infections research: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksCytomegalovirus and herpesvirus research: 2 fractional worksRespiratory and Cough-Related Research: 1 fractional worksCervical Cancer and HPV …1Cervical Cancer and HPV Research: 1 fractional worksVaccine Coverage and Hesitancy: 1 fractional worksEconomic and Financial Impacts of Cancer: 1 fractional worksSleep and related disorders: 1 fractional works
Economics and EconometricsEpidemiologyOncologyPulmonary and Respiratory Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  2. 2 Pneumonia and Respiratory Infections Epidemiology 2 works
  3. 3 Respiratory viral infections research Epidemiology 2 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 2 works
  5. 5 Cytomegalovirus and herpesvirus research Epidemiology 2 works
  6. 6 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 1 works
  7. 7 Cervical Cancer and HPV Research Epidemiology 1 works
  8. 8 Vaccine Coverage and Hesitancy Health 1 works
  9. 9 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  10. 10 Sleep and related disorders Experimental and Cognitive Psychology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.1%not open42.9%

World: 28% of research is openly available.

with international co-authors48.9%domestic only51.1%

World: 19% is written across borders.

How has MSD K.K. (Japan)'s research output changed?

Output in 2018–2022 was 108% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.